| Name | Title | Contact Details |
|---|
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
EHCEC exists to improve the quality of life through innovative, sustainable programs and services that empower men, women and youth to achieve their full potential. The organization exclusively focuses on the communities of Channelview, Crosby, Galena Park, Jacinto City, North Shore, and Sheldon. This region is home to more than 225,000 residents and lacks comprehensive services that will ultimately improve the quality of life of the people who live there.
NanoIntegris is the world's only supplier of electronically pure metallic and semiconducting single-walled carbon nanotubes
Crosstown Tree Service is a Chicago, IL-based company in the Business Services sector.
Imtra Corp is a New Bedford, MA-based company in the Business Services sector.